FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely obstetrics, and can be used to determine indications for urgent delivery in pre-eclampsia in gestational period of at least 22 weeks of gestation. To do this, the concentration of IgG in the plasma of the pregnant woman to the core region of the lipopolysaccharide is determined, and if this value is less than 64 MU/ml, the indications for urgent delivery are established.
EFFECT: method allows to reduce maternal and perinatal mortality with the development of preeclampsia by clarifying the indications for urgent delivery by non-invasive objective detection of irreversible changes in homeostasis both in the mother's body and in the fetus.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING INDICATIONS FOR URGENT DELIVERY IN PREGNANT WOMEN WITH INTRAUTERINE GROWTH RESTRICTION SYNDROME | 2017 |
|
RU2670451C1 |
| DIAGNOSTIC TECHNIQUE OF PREECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2012 |
|
RU2483311C1 |
| METHOD FOR PREDICTION OF PRETERM DELIVERY AT GESTATION PERIOD OF 24-34 WEEKS | 2017 |
|
RU2670672C1 |
| METHOD OF PREDICTING PERINATAL MORBIDITY | 2008 |
|
RU2369331C1 |
| METHOD FOR INDIVIDUAL PREDICTION OF INTRANATAL FOETAL DEATH | 2015 |
|
RU2574714C1 |
| METHOD OF PROLONGING PREGNANCY IN EARLY PRE-ECLAMPSIA | 2023 |
|
RU2803574C1 |
| METHOD OF ESTIMATING RISK TO PREGNANCY IN PRENATAL PERIOD BY RESULTS OF MASS MONITORING OF PREGNANT WOMEN AT REGIONAL LEVEL | 2012 |
|
RU2497437C1 |
| METHOD FOR INDIVIDUAL PREDICTION OF FOETAL DEATH WITH SUBSEQUENT SELECTION OF OBSTETRIC APPROACH | 2015 |
|
RU2593981C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVOURABLE MATERNAL OUTCOMES DURING PREGNANCY, CHILDBIRTH AND THE POSTPARTUM PERIOD | 2023 |
|
RU2803129C1 |
